Abbott Introduces FDA-Approved Blood Test for Colorectal Cancer Screening

Abbott has launched SimpleScreen™ CRC, a new FDA-approved blood test designed for colorectal cancer screening in adults aged 45 and older at average risk. This test, developed by Freenome, offers a less invasive alternative to traditional screening methods and demonstrated an overall sensitivity of 81.1% in a clinical study involving over 48,000 participants. Its introduction could enhance early detection efforts for colorectal cancer.